CBLN1 and type 2 diabetes mellitus: While mice experiments highlighted that the inhibition of specific Cers genes could be a targeted approach for the treatment of obesity and type 2 diabetes mellitus [82], an oral administration of rice-derived GlcCers could compensate for the epidermal loss of Cer [54].